Trial
NCT02399462
Acthar for Treatment of Post-transplant FSGS
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of North Carolina, Chapel Hill
Collaborators
Mallinckrodt
Condition
FSGS
Intervention
Acthar
Why stopped
Funding terminated prematurely
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-30